TrumpRx Platform Reshapes Pharmaceutical Pricing as Pfizer Signs On
-
最新报道：Pfizer became the first major pharmaceutical company to join the government-run TrumpRx.gov platform, which will launch in early 2026 and eliminate pharmacy benefit managers from the supply chain. The agreement implements "Most Favored Nation" pricing, matching U.S. drug costs with the lowest net prices in eight developed countries. Pfizer will discount primary care treatments by an average of 50%, with some drugs cut by up to 85% off list prices. In exchange, the company received a three-year tariff grace period and committed $70 billion to U.S. R&D. Pfizer's stock rose 6.8%, with Merck, Eli Lilly, and Johnson & Johnson also gaining as investors viewed the deal as a positive precedent for the industry.
下一篇
CZ: The security team has notified X platform to suspend the BNB Chain account first
- According to Bijie.com, CZ posted on the X platform that BNB Chain's X platform has been c...
24小时热点
热点专题
414940